Company
United StatesPublic company, NASDAQ: NPCENeuropace Inc (NASDAQ: NPCE), Mountain View, CA – FDA Inspections
Inspection records and compliance data for Neuropace Inc in Mountain View, California. 3 FDA inspections on record, last inspected September 10, 2014. Publicly traded as NASDAQ: NPCE.
Company Profile
This profile covers Neuropace Inc based in Mountain View, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected April 9, 2009. Last inspected September 10, 2014.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 10, 2014 | NAI | Medical Devices & Rad Health · Compliance: Devices | 894496 |
| March 5, 2013 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 823160 |
| April 9, 2009 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 575665 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Neuropace Inc
Stock ticker
NPCE
Exchange
NASDAQ
Share price
$12.66
Market cap
$434.5M
Price as of
November 6, 2026
FEI Number
3004426659
Address
455 Bernardo Ave, Mountain View, California 94043, United States
Country
United States
ID: d137fe94-6710-4f75-b428-1fab81c1f601